DJIA 15,318.23 138.38 0.91%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
market minute promo

Novartis

NYSE: NVS

+ Add to Portfolio

company name or ticker
Company Photos
(Click to zoom)
Working at Novartis

Positive Data on Novartis' Jakavi - Analyst Blog

Positive Data on Novartis' Jakavi - Analyst Blog
6/18/2013 by Zacks

Positive Data on Incyte's Jakafi - Analyst Blog

6/18/2013 by Zacks

This Blockbuster Biologic May Face a Steep Cliff

Neulasta generated sales north of $4 billion for Amgen in 2012, but generic competition is brewing on two continents.
6/18/2013 by DailyFinance

Good News for InterMune - Analyst Blog

6/17/2013 by Zacks

Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate

6/17/2013 by Seeking Alpha

3 Humongous Health-Care Stocks This Week

These stocks skyrocketed this week. But will gravity soon kick in?
6/15/2013 by DailyFinance

Encouraging Data on Novartis' Gilenya - Analyst Blog

Encouraging Data on Novartis' Gilenya - Analyst Blog
6/14/2013 by Zacks

1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)

Two fascinating approaches pharmaceutical companies use to discover new drugs.
6/14/2013 by DailyFinance

These 2 Healthcare Stocks Could Win Big With FDA's New 'Breakthrough' Status

6/14/2013 by Seeking Alpha

Big Pharma's Biggest Opportunity

Are emerging markets the magic cure for patent loss-related sales around the pharmaceutical industry?
6/14/2013 by DailyFinance
See More Articles...